Dr. Lee Hicks
Claim this profileBaptist Health Lexington
Studies Colorectal Cancer
Studies Colon Cancer
8 reported clinical trials
22 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
HER2 positive
2Colon Cancer
Stage III
Stage IV
BRAF negative
Affiliated Hospitals
Clinical Trials Lee Hicks is currently running
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting2 awards Phase 3
Chemotherapy + Bevacizumab + Atezolizumab
for Colorectal Cancer
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria
More about Lee Hicks
Clinical Trial Related6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Lee Hicks has experience with
- Fluorouracil
- Leucovorin
- Oxaliplatin
- Trastuzumab
- Cetuximab
- Atezolizumab
Breakdown of trials Lee Hicks has run
Colorectal Cancer
Colon Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lee Hicks specialize in?
Lee Hicks focuses on Colorectal Cancer and Colon Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Lee Hicks currently recruiting for clinical trials?
Yes, Lee Hicks is currently recruiting for 5 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Lee Hicks has studied deeply?
Yes, Lee Hicks has studied treatments such as Fluorouracil, Leucovorin, Oxaliplatin.
What is the best way to schedule an appointment with Lee Hicks?
Apply for one of the trials that Lee Hicks is conducting.
What is the office address of Lee Hicks?
The office of Lee Hicks is located at: Baptist Health Lexington, Lexington, Kentucky 40503 United States. This is the address for their practice at the Baptist Health Lexington.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.